Patents/Assignees

Helsinn Healthcare SA

10 patents in portfolio

US12606527utility2026
Crystalline Forms of an NK-1 Antagonist
0 cites
US12440485utility2025
Centrally-active Ghrelin Agonist and Medical Uses Thereof
0 cites
US12208109utility2025
Physiologically Balanced Injectable Formulations of Fosnetupitant
0 cites
US12071406utility2024
Crystalline Forms of an NK-1 Antagonist
0 cites
US12071421utility2024
Process for the Synthesis of Substituted Chloromethyl Dialkylphosphates
0 cites
US12042494utility2024
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
0 cites
US12005056utility2024
Centrally-active Ghrelin Agonist and Medical Uses Thereof
0 cites
US11884646utility2024
Fumarate Salt of (r)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea, Methods of Preparation, and Uses Thereof
0 cites
US11723902utility2023
Medical Treatments Based on Anamorelin
0 cites
US11559523utility2023
Compositions and Methods for Treating Centrally Mediated Nausea and Vomiting
0 cites